Food for Thought: The Case for Two FDAs

Is it time to rethink the combination of food regulation with drugs and devices? One powerful member of Congress thinks so. The separation could be good for FDA, and maybe for biopharma companies too. But it is also a distraction at a bad time for the agency.

Are two agencies better than one? When it comes to the Food & Drug Administration, some key members of Congress—including the chair of the House Appropriations Subcommittee that controls FDA’s budget—think the answer is yes.

For the biotech and pharmaceutical industries, the last thing anyone wants to talk about is another overhaul at FDA. The...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet